Agenus Inc news

   Watch this stock
Showing stories 1 - 10 of about 46   

Articles published

AGEN 2.66 -0.06 (-2.21%)
price chart
Agenus Inc (NASDAQ:AGEN) Receives �Buy� Rating
Dallas, Texas 03/26/2014 (FINANCIALSTRENDS) - Maxim Group has reaffirmed their �buy� rating on Agenus Inc (NASDAQ:AGEN) shares in the report that was issued to investors.
Maxim Group Reiterates "Buy" Rating for Agenus (AGEN)  Mideast Time
Related articles »  
Micro-cap Volatile Stocks: The Wet Seal (NASDAQ:WTSL), Agenus Inc ...
The Wet Seal, Inc. (NASDAQ:WTSL) rebounded on the last day of the trading week on 28th after investors found the stock to be priced appropriately, post its nearly 23 percent dip in valuation ever since it reported its 4Q and full year operational ...
Related articles »  
News Recap - Agenus Inc (NASDAQ:AGEN), Synthetic Biologics, Inc ...
Agenus Inc (NASDAQ:AGEN) remained among the day bears with 2.36% and traded with volume of 1,154,663 shares in the last session, as compared to average volume of 989,210 shares.
Big Movers: Agenus Inc (NASDAQ:AGEN), CytRx Corporation (NASDAQ:CYTR ...
New York, NY - (MARKET NEWS CALL) - 4/02/2014� Agenus Inc (NASDAQ:AGEN)'s shares dropped 6.34% to $3.10. The company on Apr. 1 announced that GlaxoSmithKline's (GSK) MAGRITi study, a Phase 3 randomized, blinded, placebo-controlled ...
Update on GSK'S MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Non ...  MarketWatch
UPDATE 1-GlaxoSmithKline throws in towel on lung cancer vaccine trial  Reuters
Related articles »  
Trend Analysis Report-Agenus Inc (AGEN), Mechel OAO (ADR) (MTL), E ...
Agenus Inc (NASDAQ:AGEN) decreased -4.67% and closed at $3.06 on a traded volume of 1.33 million shares, in comparison to 1.41 million shares of average trading volume.
Related articles »  
Stocks in the Spotlight - Agenus Inc (AGEN), Banco Santander Brasil SA (ADR ...
Las Vegas, NV - April 16, 2014 - (Tech Sonian) �Agenus Inc(NASDAQ:AGEN)is a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants.
Related articles »  
News Recap: Agenus Inc (AGEN), Gafisa SA (ADR) (NYSE:GFA), Earthlink ...
Manhattan, NY- April 02, 2014 - (Techsonian) - Agenus Inc (NASDAQ:AGEN) announced that Robert Stein, MD, PhD, Chief Scientific Officer of Agenus, presented on Agenus' checkpoint modulator portfolio and immuno-oncology strategy at the 4th Annual ...
Related articles »  
Hot Stocks - Cell Therapeutics (CTIC), Agenus Inc (AGEN), Hemispherx ...
Agenus Inc (AGEN) released its financial outcome and business highlights for the fourth quarter and year finished December 31, 2013.
Biotech Most Volatile Stocks: Agenus Inc (NASDAQ:AGEN), Agios ...
Agenus (NASDAQ:AGEN)'s stock had its �buy� rating reaffirmed by research analysts at Maxim Group in a report released on Monday,American Banking News.
Related articles »  
News Recap - Agenus Inc (NASDAQ:AGEN), ReneSola Ltd (NYSE:SOL), Nektar ...
Agenus Inc (NASDAQ:AGEN) remained among the day bulls with 4.42% and traded with volume of 1.71 million shares in the last session, as compared to average volume of 1.37 million shares.
Related articles »